Vaccines have long been seen as a potentially attractive option for treating cancer. Now a group targeting a peptide that plays a key role in CML think they may be onto a winner.
Cancer vaccine for CML shows promise
Related Articles
Drug Watch
Cancer vaccines edge towards success
Senza categoria
Guardian journalist named Best Cancer Reporter
Senza categoria
Leave a Reply